Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...
Use of the treatment has soared in popularity in recent years now taken by 2.6million women in England according to the ...
A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...
The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing ...
Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.
A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...
Millions of people with overactive bladder syndrome are prescribed daily anticholinergics. But research has linked these ...
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...
Family urges action as Korean driver with dementia causes fatal crash Seoul lacks regulations on halting driving for dementia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback